Topic: Shareholder

Closeup of stock prices

Parnell shares advance on strong Q3 revenue growth

Shares of Parnell Pharmaceuticals were up 9% in morning trading to $3.68 on Wednesday, after the company announced that its sales in the third quarter more than doubled to AU$3.6 million ($2.6 million). In the first 9 months of the year, sales grew 55% to AU$8.5 million ($6.1 million) and the company halved its net loss to AU$5.4 million ($3.9 million).